Page last updated: 2024-10-31

midazolam and Centriacinar Emphysema

midazolam has been researched along with Centriacinar Emphysema in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neema, PK1
Sinha, PK1
Varma, PK1
Rathod, RC1
Iodice, F1
Harban, F1
Walker, I1

Other Studies

2 other studies available for midazolam and Centriacinar Emphysema

ArticleYear
Simultaneous repair of bilateral multiple emphysematous bullae with a secundum atrial septal defect.
    Journal of cardiothoracic and vascular anesthesia, 2004, Volume: 18, Issue:5

    Topics: Adult; Analgesia, Epidural; Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; B

2004
Anesthetic management of a patient with bilateral congenital lobar emphysema.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:4

    Topics: Analgesics, Opioid; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Atracurium; Fenta

2008